Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

Diabetes Care. 2004 Jan;27(1):141-7.

PMID:
14693980
3.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
4.

An overview of metformin in the treatment of type 2 diabetes mellitus.

Davidson MB, Peters AL.

Am J Med. 1997 Jan;102(1):99-110. Review.

PMID:
9209206
5.

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.

Monami M, Vitale V, Ambrosio ML, Bartoli N, Toffanello G, Ragghianti B, Monami F, Marchionni N, Mannucci E.

Adv Ther. 2012 Sep;29(9):736-46. doi: 10.1007/s12325-012-0045-5. Epub 2012 Aug 24. Review.

PMID:
22923161
6.

Interventions for latent autoimmune diabetes (LADA) in adults.

Brophy S, Davies H, Mannan S, Brunt H, Williams R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD006165. doi: 10.1002/14651858.CD006165.pub3. Review.

PMID:
21901702
7.

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA).

Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Review.

PMID:
21576535
8.

The role of pioglitazone in modifying the atherogenic lipoprotein profile.

Hanefeld M.

Diabetes Obes Metab. 2009 Aug;11(8):742-56. doi: 10.1111/j.1463-1326.2009.01048.x. Epub 2009 Jun 10. Review.

PMID:
19519869
9.

Actos (pioglitazone): a new treatment for type 2 diabetes.

Lawrence JM, Reckless JP.

Hosp Med. 2001 Jul;62(7):411-6. Review.

PMID:
11480129
10.

Pharmacokinetics and clinical efficacy of pioglitazone.

Hanefeld M.

Int J Clin Pract Suppl. 2001 Sep;(121):19-25. Review.

PMID:
11594240
11.

Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.

Phung OJ, Sobieraj DM, Engel SS, Rajpathak SN.

Diabetes Obes Metab. 2014 May;16(5):410-7. doi: 10.1111/dom.12233. Epub 2013 Dec 16. Review.

PMID:
24205921
12.

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.

Derosa G, Tinelli C, Maffioli P.

Diabetes Obes Metab. 2009 Dec;11(12):1091-9. doi: 10.1111/j.1463-1326.2009.01087.x. Epub 2009 Sep 17. Review.

PMID:
19765050
13.

The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.

Dai X, Wang H, Jing Z, Fu P.

Curr Med Res Opin. 2014 Sep;30(9):1777-86. doi: 10.1185/03007995.2014.921608. Epub 2014 May 28. Review.

PMID:
24805140
14.

Diabetes update: new drugs to manage type 2 diabetes.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:20-4. Review.

PMID:
23690375
15.

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Dorkhan M, Frid A.

Vasc Health Risk Manag. 2007;3(5):721-31. Review.

16.

Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.

Garber AJ.

Diabetes Obes Metab. 2000 Jun;2(3):139-47. Review. No abstract available.

PMID:
11220549
17.

Thiazolidinediones and type 2 diabetes: new drugs for an old disease.

O'Moore-Sullivan TM, Prins JB.

Med J Aust. 2002 Apr 15;176(8):381-6. Review. Erratum in: Med J Aust 2002 Oct 7;177(7):396.

PMID:
12041635
19.

Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes.

Derosa G, Maffioli P.

Diabetes Res Clin Pract. 2011 Mar;91(3):265-70. doi: 10.1016/j.diabres.2010.08.001. Epub 2010 Sep 15. Review.

PMID:
20832133
20.

[Tough glucose reduction necessary in newly diagnosed diabetes].

Rydén M.

Lakartidningen. 2010 Nov 10-16;107(45):2810-4. Review. Swedish. No abstract available.

PMID:
21179867

Supplemental Content

Support Center